Nelson Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Nelson Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$30K	–	192
2019 Q3	$30K	Buy	+300	New	+$31.4K	0.01%	181
2016 Q3	–	Sell	-9	Closed	-$1K	–	262
2016 Q2	$1K	Buy	+9	New	+$808	﹤0.01%	261
2015 Q1	–	Sell	-174	Closed	-$18K	–	288
2014 Q4	$18K	Hold	174	–	–	0.01%	193
2014 Q3	$16K	Hold	174	–	–	0.01%	209
2014 Q2	$15K	Buy	+174	New	+$13.7K	0.01%	211

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nelson Capital Management's IBB Position: Q4 2019 in Review

Nelson Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2019, closing a stake of 300 shares — an estimated $30K sold.

Nelson Capital Management first reported a position in IBB in Q2 2014 and held it in 5 quarters. The position peaked at $30K in Q3 2019. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

Nelson Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2019 after selling out during the quarter.
Nelson Capital Management sold 300 iShares Biotechnology ETF shares in Q4 2019, an estimated $30K.
Nelson Capital Management first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 5 quarters.
Nelson Capital Management's iShares Biotechnology ETF position peaked at $30K in Q3 2019.
710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Nelson Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.